Harrow, Inc. Acquisitions, Net of Cash Acquired
Harrow, Inc. (HROW) reported Acquisitions, Net of Cash Acquired of $3.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-03-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2017-03-21
- Harrow, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2015-12-31 was $0.00.
- Harrow, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2015-09-30 was $0.00.
- Harrow, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2015-06-30 was $0.00.
- Harrow, Inc. payments to acquire businesses, net of cash acquired for the quarter ending 2015-03-31 was $3.00M.
- Harrow, Inc. payments to acquire businesses, net of cash acquired for fiscal 2015 was $3.00M, a 372.21% increase from fiscal 2014.
- Harrow, Inc. payments to acquire businesses, net of cash acquired for fiscal 2014 was $636.37K.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-21 | $0.00 derived: sum of 2 quarters · filed 2017-03-21 | $0.00 derived: sum of 3 quarters · filed 2017-03-21 | $3.00M 10-K · filed 2017-03-21 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $3.00M 10-Q · filed 2016-11-14 | $3.00M derived: sum of 4 quarters · filed 2016-11-14 |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $3.00M 10-Q · filed 2016-08-15 | $3.00M derived: sum of 3 quarters · filed 2016-08-15 | $3.00M derived: sum of 4 quarters · filed 2016-08-15 |
| 2015-03-31 | $3.00M 10-Q · filed 2016-05-12 | $3.00M derived: sum of 2 quarters · filed 2016-05-12 | $3.00M derived: sum of 3 quarters · filed 2016-05-12 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $0.00 derived: sum of 2 quarters · filed 2015-03-12 | $636.37K 10-K · filed 2015-03-12 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $636.37K 10-Q · filed 2014-11-12 | ||
| 2014-06-30 | $636.37K 10-Q · filed 2014-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |